Model
Edge
Eagle Pharmaceuticals, Inc.
0001545253
Filing Type
4
Filing Date
3/1/2022
Updated
3/2/22, 11:05 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership